comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists

comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Targeting the weight within: obesity pharmacotherapy in disease comparing cardiovascular and kidney outcomes

Name: comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Targeting the weight within: obesity pharmacotherapy in disease comparing cardiovascular and kidney outcomes
Brand: www.rasophiles.fr
SKU: 93918076020
Price: 22.61 USD
Availability: InStock
Rating: 4.1413 (16 reviews)

SKU: 93918076020

4.1

USD22.61 USD67.61

Pay in 4 interest-free payments of $5.65 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 29 - Sep 3

Description

10.1016/j.brainresbull.2007.07.011 172 MorenoJ

Polzer O, Kinloch E, Fitzsimons CP (2025) Cellular senescence, neuroinflammation, and microRNAs: possible interactions driving aging and neurodegeneration in the hippocampal neurogenic niche

Regarding the signaling pathway that is involved in autophagy induction, the present study demonstrated that PFOS induced ERK1/2 and ER stress activation, leading to autophagy induction with an increased expression of Beclin and LC3BII